Endurance RP Limited (0575.HK)
Chart Events
Performance Outlook
| Previous Close | 0.118 |
| Open | 0.120 |
| Bid | 0.120 x 0 |
| Ask | 0.124 x 0 |
| Day's Range | 0.117 - 0.138 |
| 52 Week Range | 0.105 - 0.203 |
| Volume | |
| Avg. Volume | 1,826,235 |
| Market Cap | 287.93M |
| Beta (5Y Monthly) | 0.92 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.021 |
| Earnings Date | Mar 30, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Feb 08, 2013 |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for 0575.HK
Related Research
- PR Newswire
Deep Longevity Launched a Free Self-help Application, FuturSelf, Powered by Research Conducted with Harvard Medical School, on Optimizing Future Well-being with Artificial Intelligence
Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announce its collaboration with Dr. Nancy Etcoff of Harvard Medical School. Dr. Etcoff is widely recognized in the field of psychology and is a member of the Harvard University Mind/Brain/Behavior Initiative where she teaches a seminar on "The Sci
- PR Newswire
Endurance Longevity Signed Exclusive Licence Agreement to Commercialise Fortacin™ in the Israeli and Balkan regions
Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) announced that Plethora Solutions Limited (Solutions), a wholly owned subsidiary of the Company has entered into an exclusive Licence Agreement with K.S. KIM International (SK-Pharma) Ltd. on 14 December 2021 in respect of the rights to commercialise and distribute Fortacin™, the novel treatment for PE in the Israeli and Balkan regions.
- PR Newswire
Deep Longevity Launches Longevity Medicine Course for Physicians with Industry Experts
Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK)'s Deep Longevity, Inc, a company acquired on 14 December 2020 which develops artificial intelligence to track human aging and extend productive longevity, is pleased to announce that the very first, highly popular and now also CME accredited online course titled "The Introduction to Longevity Medicine for Physicians", developed collaboratively between leading AI-an
